Noblesville, IN, United States of America

Shawn Christopher Miller

This inventor holds 13 USPTO granted patents, plus 1 CIPO patent. Top assignees: Eli Lilly and Company, Eli Lilly, Hoechst Marion Roussel. Active years: 1996-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shawn Christopher Miller. Retrieved from https://idiyas.com/inventor/shawn-christopher-miller-srni9f5f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 61.5


Average Co-Inventor Count = 7.7

ph-index = 6

Forward Citations = 144(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1996 - 2000)
  • Noblesville, IN (US) (2002 - 2006)
  • Morgantown, IN (US) (2007 - 2011)

Company Filing History:


Years Active: 1996-2011

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: **The Innovative Mind of Shawn Christopher Miller**

Introduction

Shawn Christopher Miller, a prominent inventor based in Noblesville, Indiana, has made significant contributions to the field of pharmacology with a total of 13 patents to his name. His work primarily focuses on chemicals that serve as antagonists for certain neurotransmitter receptors, paving the way for new treatments for various mental health disorders.

Latest Patents

Among his latest inventions are the compounds known as N-(2-arylethyl)benzylamines, which act as antagonists of the 5-HT6 receptor. The present invention not only provides the chemical formulas for these antagonists but also includes pharmaceutically acceptable salts and compositions designed for therapeutic use. These innovations have potential applications in treating a wide range of disorders associated with the 5-HT6 receptor, including schizophrenia, anxiety, Alzheimer's disease, and other cognitive impairments. By administering these compounds, patients may experience significant improvements in their conditions.

Career Highlights

Shawn's professional journey includes influential positions at Eli Lilly and Company, a well-established name in the pharmaceutical industry. His experience at Eli Lilly has equipped him with the knowledge and expertise to innovate in the field of drug development and mental health treatment.

Collaborations

Throughout his career, Shawn has collaborated with noteworthy individuals such as Matthew Joseph Fisher and Wayne A. Spitzer. This collaborative spirit reflects the importance of teamwork in the innovation process, as working alongside other experts can yield groundbreaking discoveries and advancements.

Conclusion

Shawn Christopher Miller stands out as an inventive force in the pharmaceutical sector. With a solid portfolio of patents and crucial contributions to mental health treatment, his work continues to have a positive impact on the lives of many. As he continues to innovate, the medical community eagerly anticipates the future possibilities that Shawn's inventions will bring.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…